Case Study


A 60-year-old male presented with complaints of sudden onset blurred vision and floaters in his left eye for the past week.

Retinal capillary nonperfusion

He had a history of poorly controlled diabetes mellitus and hypertension. There was no history of trauma or previous ocular surgeries.

Examination Results:
  • Visual Acuity: 20/20 in the right eye, 20/80 in the left eye.
  • Fundus Examination: Extensive areas of retinal whitening and hemorrhages in the mid-peripheral retina of the left eye. Cotton wool spots were observed.
  • Fluorescein Angiography: Large areas of capillary nonperfusion and leakage in the affected regions.
  • Optical Coherence Tomography (OCT): Significant macular edema and intraretinal fluid in the left eye.
  • Systemic Workup: Elevated HbA1c levels and blood pressure of 160/100 mmHg.

The patient was diagnosed with Retinal Capillary Nonperfusion according to previous examination results.

Retinal capillary nonperfusion disease entity


Retinal capillary nonperfusion is a complex and critical disease entity characterized by the inadequate or complete loss of blood flow within the intricate capillary networks of the retina.

It results from a variety of underlying conditions such as diabetic retinopathy, retinal vein occlusions, or retinal ischemia.

This disruption in perfusion can lead to severe visual impairment by compromising the essential retinal structures responsible for vision.

The situation may further worsen through the induction of neovascularization, a process where new, often fragile, and leaky blood vessels form in response to ischemic stress.

This can culminate in significant complications such as macular edema, where fluid accumulates in the central part of the retina, and vitreous hemorrhage, where blood leaks into the gel-like substance filling the eye.

Early diagnosis, vigilant monitoring, and timely intervention are crucial to mitigate the risk of permanent vision loss.

Retinal capillary nonperfusion Pathophysiology


Retinal capillary nonperfusion occurs when there is an obstruction in the small blood vessels supplying the retina.

This can result from a variety of causes, including diabetic retinopathy, retinal vein occlusion, and hypertensive retinopathy.

The loss of capillary perfusion leads to retinal ischemia, triggering a cascade of pathological changes such as increased vascular permeability, retinal edema, and neovascularization.

Persistent ischemia can cause irreversible damage to the retinal tissue, leading to vision loss.

Retinal capillary nonperfusion Epidemiology


Retinal capillary nonperfusion is commonly associated with systemic diseases such as diabetes mellitus and hypertension.

It predominantly affects older adults, although it can occur in younger individuals with severe systemic conditions.

The prevalence is higher in populations with poor control of systemic risk factors, highlighting the importance of comprehensive management of these conditions.

Clinical Features


The clinical presentation of retinal capillary nonperfusion can vary depending on the extent and location of the ischemia. Common symptoms include:

  • Blurred Vision: Often the first symptom, caused by macular edema or ischemia.
  • Floaters: Resulting from vitreous hemorrhage or retinal detachment.
  • Visual Field Defects: Peripheral vision loss may occur due to ischemia in the mid-peripheral retina.
  • Sudden Vision Loss: In severe cases, particularly if neovascular complications arise.

Retinal capillary nonperfusion

Examination Findings


  • Fundus Examination: Retinal whitening, hemorrhages, and cotton-wool spots indicate ischemia. Neovascularization may be observed in advanced cases.
  • Fluorescein Angiography: Reveals areas of capillary nonperfusion, vascular leakage, and neovascularization.
  • Optical Coherence Tomography (OCT): Shows macular edema, intraretinal fluid, and structural retinal changes.
  • Systemic Evaluation: Elevated blood glucose and hypertension are common findings.

Retinal capillary nonperfusion Differential Diagnosis


The differential diagnosis for retinal capillary nonperfusion includes several other conditions with similar clinical features:

  • Diabetic Retinopathy: Characterized by microaneurysms, hemorrhages, and neovascularization in patients with diabetes.
  • Retinal Vein Occlusion: Presents with retinal hemorrhages, macular edema, and dilated, tortuous veins.
  • Hypertensive Retinopathy: Retinal changes due to chronic hypertension, including arteriosclerosis and flame-shaped hemorrhages.
  • Ocular Ischemic Syndrome: Severe carotid artery stenosis leading to chronic ocular ischemia.

Retinal capillary nonperfusion Diagnosis


Diagnosing retinal capillary nonperfusion involves a combination of clinical evaluation and imaging studies:

  • Clinical Examination: Detailed fundus examination to identify ischemic changes and neovascularization.
  • Fluorescein Angiography: Essential for visualizing capillary nonperfusion and leakage.
  • Optical Coherence Tomography (OCT): Provides detailed imaging of retinal structures, highlighting macular edema and retinal thickening.
  • Systemic Workup: Includes blood glucose, HbA1c, and blood pressure measurements to assess underlying systemic conditions.

Retinal capillary nonperfusion Management


Management of retinal capillary nonperfusion aims to address the underlying cause and prevent further retinal damage:

  • Control of Systemic Conditions: Optimal management of diabetes and hypertension is crucial.
  • Anti-VEGF Therapy: Intravitreal injections of anti-VEGF agents can reduce macular edema and neovascularization.
  • Laser Photocoagulation: Targeted laser treatment of ischemic areas to reduce the risk of neovascular complications.
  • Surgical Intervention: Vitrectomy may be necessary in cases of vitreous hemorrhage or tractional retinal detachment.
  • Regular Monitoring: Frequent follow-up to monitor disease progression and treatment response.

Retinal capillary nonperfusion Prognosis


The prognosis for retinal capillary nonperfusion depends on the severity of ischemia and the effectiveness of treatment.

Early diagnosis and aggressive management of systemic conditions can significantly improve outcomes. However, chronic ischemia and recurrent neovascularization can lead to permanent visual impairment.

Prevention 


Preventive measures focus on managing systemic risk factors such as diabetes and hypertension. Public health initiatives should emphasize the importance of regular ophthalmic examinations for at-risk populations.

Early detection and intervention are key to preventing severe visual impairment in patients with retinal capillary nonperfusion.

Conclusion


Retinal capillary nonperfusion is a serious condition with significant implications for visual health. Understanding its pathophysiology, clinical features, and management strategies is essential for optimizing patient care.

Advances in diagnostic imaging and therapeutic approaches offer hope for better management and prognosis.

Comprehensive systemic management and regular monitoring are critical components of care for individuals affected by retinal capillary nonperfusion.

Would you have interest in taking retinal images with your smartphone?

Fundus photography is superior to fundus analysis as it enables intraocular pathologies to be photo-captured and encrypted information to be shared with colleagues and patients.

Recent technologies allow smartphone-based attachments and integrated lens adaptors to transform the smartphone into a portable fundus camera and Retinal imaging by smartphone.

RETINAL IMAGING BY YOUR SMARTPHONE

References


  1. Aiello, L. P., Avery, R. L., Arrigg, P. G., Keyt, B. A., Jampel, H. D., Shah, S. T., … & Ferrara, N. (1994). Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. New England Journal of Medicine, 331(22), 1480-1487.
  2. Browning, D. J., & Fraser, C. M. (2004). Retinal vein occlusions: the clinical findings, natural history, and management. Comprehensive Ophthalmology Update, 5(1), 25-44.
  3. Wong, T. Y., & Mitchell, P. (2004). The eye in hypertension. The Lancet, 364(9453), 912-923.
  4. Antonetti, D. A., Klein, R., & Gardner, T. W. (2012). Diabetic retinopathy. New England Journal of Medicine, 366(13), 1227-1239.
  5. McAllister, I. L., Gillies, M. E., Smithies, L. A., & Hocking, P. (1992). The treatment of macular oedema due to branch retinal vein occlusion by argon laser photocoagulation. Australian and New Zealand Journal of Ophthalmology, 20(2), 157-163.

RETINAL IMAGING BY YOUR SMARTPHONE